Our experts come from diverse backgrounds in traditional CBD extraction and large-scale distillation. This unique collaboration has led us to develop groundbreaking techniques to economize the processing of hemp biomass into CBD distillate and isolate at a scale to match this growing industry.
Through the application of time-tested chemistry techniques and state-of-the-art equipment, we have built facilities able to process up to a combined 76,000kg of biomass per month.
With a 5.3% CBD hemp biomass input, our CBD isolate output capabilities are estimated to be up to 2,425kg per month.
We believe the rush to produce CBD across the globe will soon commoditize the sale of CBD isolate in particular. Cost-effective extraction and formulation techniques allow us to make sure we are providing customers with the highest quality wholesale CBD products at fair market value.
Through a joint venture with Dragonfly Biosciences, we have built a soon-to-be, GMP-certified extraction facility in Southern Romania. Focused on a tolling model this facility will enable a steady revenue stream once permitting is complete.
If the first stage in creation is imagination, the second is will. The Nexus facility has taken our Origin technology to the next level using a refined approach that we believe will even further widen the gap between Stillcanna and the other extraction specialists in the space.
As we look even further to the future, we begin to lay the groundwork for Horizon, our flagship, large-scale, GMP extraction facility. By scaling up our technologies from the Nexus facility, this massive, cutting-edge CBD extraction operation will enable us to produce a vast supply of CBD distillate and isolate solidifying Stillcanna as a major player in the global CBD market for years to come.